세계의 카트리지 시장 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2024-2032년)

The Global Cartridges Market reached a valuation of USD 1.8 billion in 2023 and is anticipated to grow at a CAGR of 7.6% from 2024 to 2032. This growth is largely fueled by the rising demand for user-friendly, self-administered drug delivery systems, particularly for chronic conditions like diabetes and autoimmune diseases. The development of advanced materials, including biocompatible glass and polymers, enhances drug stability and compatibility, making cartridges an increasingly attractive option for pharmaceutical manufacturers and patients.

In terms of preparation, the market is divided into ready-to-use (RTU) and ready-to-sterilize (RTS) segments. The RTU segment is projected to experience significant growth at an 8% CAGR through 2032, driven by its convenience and efficiency for healthcare providers and patients. RTU cartridges are commonly used to deliver biologics and insulin, ensuring precise dosing while minimizing contamination risks. The trend toward self-administration and home healthcare solutions further supports the demand for RTU cartridges, securing their leading position in the market.

By application, the global cartridge market is categorized into small molecules and biologics. Biologics, which accounted for a substantial 70.1% of the market share in 2023, drive the demand for cartridges due to the critical need for precise, contamination-free delivery systems. Cartridges designed for biological drugs, such as monoclonal antibodies and recombinant proteins, are essential in ensuring accurate dosing and maintaining drug efficacy and safety. The expanding focus on personalized medicine and the growing pipeline of biologic therapies underscores the importance of cartridge-based delivery systems, strengthening their presence within the pharmaceutical sector.

The United States holds a dominant position in the North American cartridges market and is expected to maintain this lead with a projected CAGR of 7.3% during the forecast period. The U.S. market benefits from a well-established pharmaceutical and biotech industry, which prioritizes the development of innovative drug delivery methods. A strong healthcare infrastructure, coupled with the increasing acceptance of self-administration devices, contributes to market growth. Regulatory support and an emphasis on patient-centric solutions also enhance the U.S.'s standing within the North American market.

Overall, the global cartridges market is set for steady expansion as demand for advanced, user-friendly drug delivery systems grows. With ongoing innovations in materials and design, cartridges are increasingly becoming essential tools in chronic disease management and personalized healthcare solutions, shaping the future of drug delivery across diverse therapeutic areas.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of chronic disease
    • 3.2.1.2 Growing preference for self-administration
    • 3.2.1.3 Growing advances in pharmaceutical drug delivery and manufacturing technology
    • 3.2.1.4 Rise in biologics and biosimilars research activities
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Hight cost and complexity in manufacturing
    • 3.2.2.2 Stringent regulatory framework
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Future market trends
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Preparation, 2021 - 2032 ($ Mn and Units)

• 5.1 Key trends
• 5.2 Ready to Use (RTU)
• 5.3 Ready to Sterilize (RTS)

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn and Units)

• 6.1 Key trends
• 6.2 Small molecules
• 6.3 Biologics

Chapter 7 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn and Units)

• 7.1 Key trends
• 7.2 Glass
• 7.3 Polymer

Chapter 8 Market Estimates and Forecast, By Size, 2021 - 2032 ($ Mn and Units)

• 8.1 Key trends
• 8.2 <1 ml
• 8.3 1 ml - 2 ml
• 8.4 3 ml - 5 ml
• 8.5 6 ml - 10 ml
• 8.6 10 - 20 ml
• 8.7 20 - 30 ml
• 8.8 >30 ml

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn and Units)

• 9.1 Key trends
• 9.2 Hospitals & clinics
• 9.3 Pharma & biotech companies
• 9.4 Contract Development and Manufacturing Organizations (CDMOs)
• 9.5 Other end user

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn and Units)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 AptarGroup
• 11.2 Baxter
• 11.3 Becton, Dickinson and Company (BD)
• 11.4 Corning
• 11.5 Daikyo Seiko
• 11.6 Datwyler Holding
• 11.7 Gerresheimer AG
• 11.8 Merck KGaA
• 11.9 Nipro
• 11.10 Schott Group
• 11.11 Shandong Medicinal Glass
• 11.12 Stevanato Group
• 11.13 Transcoject
• 11.14 West Pharmaceutical Services